학술논문

Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.
Document Type
Article
Source
International Journal of Molecular Sciences. Jun2022, Vol. 23 Issue 12, p6400-6400. 19p.
Subject
*GLYCOSAMINOGLYCANS
*LUNGS
*CHRONIC obstructive pulmonary disease
*CYSTIC fibrosis
*MOLECULAR interactions
*RESPIRATORY diseases
*EXTRACELLULAR matrix
Language
ISSN
1661-6596
Abstract
In the lung, glycosaminoglycans (GAGs) are dispersed in the extracellular matrix (ECM) occupying the interstitial space between the capillary endothelium and the alveolar epithelium, in the sub-epithelial tissue and in airway secretions. In addition to playing key structural roles, GAGs contribute to a number of physiologic processes ranging from cell differentiation, cell adhesion and wound healing. Cytokine and chemokine–GAG interactions are also involved in presentation of inflammatory molecules to respective receptors leading to immune cell migration and airway infiltration. More recently, pathophysiological roles of GAGs have been described. This review aims to discuss the biological roles and molecular interactions of GAGs, and their impact in the pathology of chronic airway diseases, such as cystic fibrosis and chronic obstructive pulmonary disease. Moreover, the role of GAGs in respiratory disease has been heightened by the current COVID-19 pandemic. This review underlines the essential need for continued research aimed at exploring the contribution of GAGs in the development of inflammation, to provide a better understanding of their biological impact, as well as leads in the development of new therapeutic agents. [ABSTRACT FROM AUTHOR]